MissionIR Articles
Category: Kairos Pharma Ltd. KAPA
-
Kairos Pharma Ltd. (NYSE: KAPA) Developing Innovative Therapies to Tackle Cancer Drug Resistance, Immune Suppression
Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, is dedicated to advancing innovative oncology therapies to overcome critical challenges in cancer drug resistance and immune suppression, two significant challenges to effective cancer treatment. With…
-
Kairos Pharma Ltd. (NYSE American: KAPA) Is ‘One to Watch’
Kairos Pharma (NYSE American: KAPA) is a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics that target drug resistance and immune suppression, two significant barriers in effective cancer treatment. By addressing these mechanisms, Kairos…
Search Articles
Latest Articles
- MissionIRNewsBreaks – USA Rare Earth, Inc. (Nasdaq: USAR) to Acquire Texas Mineral Resources (OTCQB: TMRC) in $73M Stock Deal
- MissionIRNewsBreaks – Standex International Corporation (NYSE: SXI) Divests Federal Industries Business for Approximately $70M
- MissionIRNewsBreaks – FG Nexus Inc. (NASDAQ: FGNX, FGNXP) Ranked Top SPAC Sponsor by Median Returns in EarlyBirdCapital Study
- Trilogy Metals Inc.’s Joint Venture, Ambler Metals, Strengthens Management as U.S. Mineral Policy Gains Momentum
- MissionIRNewsBreaks – Pelican Acquisition Corp. (NASDAQ: PELI) Announces Ashiq Merchant as CFO of Post-Merger Greenland Energy